Citigroup
PDSB icon

Citigroup’s PDS Biotechnology PDSB Stock Holding History

Citigroup’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,393
Closed -$7.23K – 6282
2025
Q4 		$7.23K Buy
9,393
+9,369
+39,038% +$8.45K ﹤0.01% 5149
2025
Q3 		$24 Buy
+24
New +$28 ﹤0.01% 5892
2025
Q1 		– Sell
-20
Closed -$33 – 5858
2024
Q4 		$33 Sell
20
-2
-9% -$5 ﹤0.01% 5735
2024
Q3 		$84 Sell
22
-23,481
-100% -$78.3K ﹤0.01% 5545
2024
Q2 		$68.9K Buy
23,503
+18,719
+391% +$59.9K ﹤0.01% 4411
2024
Q1 		$18.9K Buy
4,784
+770
+19% +$3.97K ﹤0.01% 5041
2023
Q4 		$19.9K Buy
4,014
+3,997
+23,512% +$19.9K ﹤0.01% 4988
2023
Q3 		$86 Sell
17
-8,310
-100% -$45.5K ﹤0.01% 5443
2023
Q2 		$41.9K Buy
8,327
+8,067
+3,103% +$52.8K ﹤0.01% 4731
2023
Q1 		$1.6K Hold
260
– – ﹤0.01% 5116
2022
Q4 		$3.43K Buy
+260
New +$1.83K ﹤0.01% 5112
2022
Q1 		– Sell
-1,870
Closed -$15K – 6537
2021
Q4 		$15K Buy
1,870
+1,080
+137% +$11.6K ﹤0.01% 5475
2021
Q3 		$12K Sell
790
-210
-21% -$2.62K ﹤0.01% 5423
2021
Q2 		$13K Buy
+1,000
New +$7.81K ﹤0.01% 5540
2018
Q2 		– Sell
-125
Closed -$3K – 7695
2018
Q1 		$3K Buy
125
+74
+145% +$19.9K ﹤0.01% 7309
2017
Q4 		$10K Buy
51
+48
+1,600% +$9.66K ﹤0.01% 7047
2017
Q3 		$1K Sell
3
-4
-57% -$827 ﹤0.01% 7143
2017
Q2 		$1K Buy
7
+3
+75% +$591 ﹤0.01% 7182
2017
Q1 		$1K Sell
4
-814
-100% -$161K ﹤0.01% 7093
2016
Q4 		$204K Buy
+818
New +$186K ﹤0.01% 5259
2016
Q3 		– Sell
-81
Closed -$16K – 7151
2016
Q2 		$16K Sell
81
-264
-77% -$46.7K ﹤0.01% 6285
2016
Q1 		$64K Buy
345
+218
+172% +$39K ﹤0.01% 5971
2015
Q4 		$32K Buy
+127
New +$40.9K ﹤0.01% 6228

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citigroup's PDSB Position: Q1 2026 in Review

Citigroup sold out of PDS Biotechnology (PDSB) in Q1 2026, closing a stake of 9,393 shares — an estimated $7.23K sold.

Citigroup first reported a position in PDSB in Q4 2015 and held it in 23 quarters. The position peaked at $204K in Q4 2016. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • Citigroup reported no remaining PDS Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 9,393 PDS Biotechnology shares in Q1 2026, an estimated $7.23K.
  • Citigroup first reported a position in PDS Biotechnology in Q4 2015 and held it in 23 quarters.
  • Citigroup's PDS Biotechnology position peaked at $204K in Q4 2016.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.